220122-59-8 Usage
Uses
Used in Pharmaceutical Industry:
Phenol, 3-[(3R,4R)-1-[(2S)-2-amino-3-methylbutyl]-3,4-dimethyl-4-piperidinyl]is used as a pharmaceutical intermediate for the synthesis of various drugs. Its unique structure and functional groups can be utilized to create new compounds with potential therapeutic effects.
Used in Synthetic Chemistry:
In synthetic chemistry, Phenol, 3-[(3R,4R)-1-[(2S)-2-amino-3-methylbutyl]-3,4-dimethyl-4-piperidinyl]can be used as a building block for the synthesis of more complex molecules. Its versatile structure allows for further functionalization and modification, enabling the development of new compounds with specific properties and applications.
Used in Research and Development:
Phenol, 3-[(3R,4R)-1-[(2S)-2-amino-3-methylbutyl]-3,4-dimethyl-4-piperidinyl]can be employed in research and development for studying its chemical properties, reactivity, and potential interactions with other molecules. This knowledge can be applied to optimize its use in various applications, such as drug discovery or material science.
Check Digit Verification of cas no
The CAS Registry Mumber 220122-59-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,0,1,2 and 2 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 220122-59:
(8*2)+(7*2)+(6*0)+(5*1)+(4*2)+(3*2)+(2*5)+(1*9)=68
68 % 10 = 8
So 220122-59-8 is a valid CAS Registry Number.
220122-59-8Relevant articles and documents
Identification of an Opioid κ Receptor Subtype-Selective N-Substituent for (+) - (3R,4K) -Dimethyl-4- (3-hy droxyphenyl)piperidine
Thomas, James B.,Fall, Michael J.,Cooper, Julie B.,Rothman, Richard B.,Wayne Mascarella,Xu, Heng,Partilla, John S.,Dersch, Christina M.,McCullough, Karen B.,Cantrell, Buddy E.,Zimmerman, Dennis M.,Ivy Carroll
, p. 5188 - 5197 (2007/10/03)
A three-component library of compounds was prepared in parallel using multiple simultaneous solution-phase synthetic methodology. The compounds were biased toward opioid receptor antagonist activity by incorporating (+)-(3,4)-dimethyl-4-(3-hydroxyphenyl)p